EO771, is it a well-characterized cell line for mouse mammary cancer model? Limit and uncertainty

Cancer Med. 2020 Nov;9(21):8074-8085. doi: 10.1002/cam4.3295. Epub 2020 Oct 7.

Abstract

Among mouse mammary tumor models, syngeneic cell lines present an advantage for the study of immune response. However, few of these models are well characterized. The tumor line EO771 is derived from spontaneous breast cancer of C57BL/6 mice. These cells are widely used but are referenced under different names: EO771, EO 771, and E0771. The characteristics of the EO771 cells are well described but some data are contradictory. This cell line presents the great interest of developing an immunocompetent neoplastic model using an orthotopic implantation reflecting the mammary tumors encountered in breast cancer patients. This review presents the phenotype characteristics of EO771 and its sensitivity to nutrients and different therapies such as radiotherapy, chemotherapy, hormone therapy, and immunotherapy.

Keywords: antineoplastic agents; breast neoplasms; hormonal receptors; inbred C57BL; mice; murine cell line.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Cell Line, Tumor
  • Female
  • Genetic Therapy
  • Immunotherapy*
  • Mammary Glands, Animal / drug effects*
  • Mammary Glands, Animal / metabolism
  • Mammary Glands, Animal / pathology
  • Mammary Glands, Animal / radiation effects*
  • Mammary Neoplasms, Experimental / metabolism
  • Mammary Neoplasms, Experimental / pathology
  • Mammary Neoplasms, Experimental / therapy*
  • Mice
  • Mice, Inbred C57BL
  • Phenotype
  • Radiotherapy
  • Species Specificity

Substances

  • Antineoplastic Agents